Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Antonio Cuneo et al.|The Lancet Haematology|2020Cited by 553
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemiaAdriano Venditti, Sergio Amadori, Alfonso Piciocchi et al.|Blood|2019Cited by 215
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Mohamad Mohty, Myriam Labopin et al.|Bone Marrow Transplantation|2020Cited by 202
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow TransplantationMohamad Mohty, Rafael F. Duarte, Kai Hübel et al.|Bone Marrow Transplantation|2014Cited by 192
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with <i>FLT3</i>-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAli Bazarbachi, Mohamad Mohty, Gesine Bug et al.|Haematologica|2020Cited by 137